newsfilter
← Latest News
PR Newswire·

Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided updates on the Company's clinical...